Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study

Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated the effectiveness and safety of nintedanib in routine clinical practice. Patients diagnosed with IPF, as per gu...

Full description

Bibliographic Details
Published in:	ERJ Open Research
Main Authors:	Katerina Antoniou, Katerina Markopoulou, Argyrios Tzouvelekis, Athina Trachalaki, Eirini Vasarmidi, Jiannis Organtzis, Vasilios Tzilas, Evangelos Bouros, Georgia Kounti, Christina Rampiadou, Serafeim-Chrysovalantis Kotoulas, Fotini Bardaka, Eleni Bibaki, Evangelia Fouka, Georgios Meletis, Stavros Tryfon, Zoe Daniil, Despina Papakosta, Demosthenes Bouros
Format:	Article
Language:	English
Published:	European Respiratory Society 2020-01-01
Online Access:	http://openres.ersjournals.com/content/6/1/00172-2019.full

Similar Items

A role of antifibrotics in the treatment of Scleroderma-ILD?
by: Katerina M. Antoniou, et al.
Published: (2020-01-01)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
by: Argyrios Tzouvelekis, et al.
Published: (2017-11-01)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
by: Argyrios Tzouvelekis, et al.
Published: (2018-01-01)

Metabolic Disorders in Chronic Lung Diseases
by: Ourania Papaioannou, et al.
Published: (2018-01-01)

Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies
by: Vasilios Tzilas, et al.
Published: (2024-04-01)

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2020-02-01)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
by: Argyris Tzouvelekis, et al.
Published: (2020-04-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01)

Serum biomarkers in interstitial lung diseases
by: Anevlavis Stavros, et al.
Published: (2005-07-01)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2011-01-01)

Antisynthetase syndrome with predominant lung involvement. An easy to miss diagnosis
by: V. Tzilas, et al.
Published: (2023-07-01)

Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
by: Foteini Malli, et al.
Published: (2019-03-01)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
by: Kostas Archontogeorgis, et al.
Published: (2012-01-01)

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
by: Anevlavis Stavros, et al.
Published: (2004-11-01)

Reversed halo sign in radiation induced organizing pneumonia: natural course of the underlying pathophysiology
by: V. Tzilas, et al.
Published: (2021-09-01)

Reversed halo sign in radiation induced organizing pneumonia: natural course of the underlying pathophysiology
by: V. Tzilas, et al.
Published: (2021-09-01)

Biologic Treatments in Interstitial Lung Diseases
by: Theodoros Karampitsakos, et al.
Published: (2019-03-01)

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
by: Argyris Tzouvelekis, et al.
Published: (2012-01-01)

In pursuit of personalized medicine in fibrotic interstitial lung diseases. Divide and conquer
by: V. Tzilas, et al.
Published: (2024-03-01)

Differential immunohistochemical expression of hTERT in lung cancer patients with and without idiopathic pulmonary fibrosis
by: G. Gomatou, et al.
Published: (2024-05-01)

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
by: Theodoros Karampitsakos, et al.
Published: (2023-01-01)

Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis
by: Matthaios Katsaras, et al.
Published: (2025-04-01)

Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis
by: Athina Trachalaki, et al.
Published: (2021-06-01)

Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians... perspective
by: S.G. Theodorakis, et al.
Published: (2023-01-01)

Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians’ perspective
by: S.G. Theodorakis, et al.
Published: (2023-01-01)

Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape
by: Stavros Tsotsolis, et al.
Published: (2023-05-01)

Nicotine replacement therapy as a smoking cessation tool for adolescents: an update
by: Ioannis Beis, et al.
Published: (2025-02-01)

Smoking and Obstructive Sleep Apnea: Is There An Association between These Cardiometabolic Risk Factors?—Gender Analysis
by: Despoina Ioannidou, et al.
Published: (2021-10-01)

Novel Treatment for Pre-XDR Tuberculosis Linked to a Lethal Case of Acute Myocarditis
by: Serafeim-Chrysovalantis Kotoulas, et al.
Published: (2024-09-01)

Two Cases of Testicular Tuberculosis and Review of the Recent Literature
by: Ifigeneia Nakou, et al.
Published: (2024-09-01)

Idiopathic Pulmonary Hemosiderosis in Adults: A Case Report and Review of the Literature
by: Argyris Tzouvelekis, et al.
Published: (2012-01-01)

Editorial: Cardiopulmonary exercise testing in chronic diseases
by: Aikaterini Gakidi, et al.
Published: (2025-04-01)

Endobronchial melanoma metastasis. A rare relapse
by: Anastasios Palamidas, et al.
Published: (2025-01-01)

Eosinophilia associated with nintedanib therapy
by: Kiana A. Banafshay, et al.
Published: (2025-01-01)

Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?
by: Paschalis Steiropoulos, et al.
Published: (2010-01-01)

Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma
by: Serafeim-Chrysovalantis Kotoulas, et al.
Published: (2023-07-01)

SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts
by: Theodoros Karampitsakos, et al.
Published: (2023-03-01)

Preparation and characterization of nintedanib nano-liposomes
by: RAO Le, et al.
Published: (2024-07-01)

Nintedanib-Induced Renal Thrombotic Microangiopathy
by: Takeshi Fujita, et al.
Published: (2021-07-01)

Phenotyping exercise limitation of patients with Interstitial Fibrosing Lung Disease: the importance of exercise hemodynamics
by: E. Panagiotidou, et al.
Published: (2024-03-01)